
Aflac Reports $17.2 Billion Revenue Amid Japan Market Dominance and $3.5 Billion Share Repurchases
Aflac IncorporatedDescription
What this story covers
Noah and Ash break down Aflac’s 2025 10-K, highlighting its leadership in Japan’s cancer insurance market, the impact of yen volatility on its $17.2 billion revenue, and a robust capital strategy including $3.5 billion in share repurchases.
Story snapshot
CompanyAflac Incorporated
TickerAFL
VariantStandard detailed
Duration11:46
Filing type10-K
PeriodAnnual 2025
IndustryFinancial Services
Accession0001628280-26-011402
Sources1
Full Story Script
Content not available for this story.